Post-translational modifications linked to preclinical Alzheimer's disease-related pathological and cognitive changes

被引：2
作者：
Abiose, Olamide [1 ,2 ,9 ]
Rutledge, Jarod [3 ,4 ]
Moran-Losada, Patricia [1 ,2 ,3 ]
Belloy, Michael E. [1 ]
Wilson, Edward N. [1 ,2 ]
He, Zihuai [1 ,5 ]
Trelle, Alexandra N. [1 ]
Channappa, Divya [1 ]
Romero, America [1 ]
Park, Jennifer [1 ]
Yutsis, Maya V. [1 ]
Sha, Sharon J. [1 ]
Andreasson, Katrin I. [1 ,2 ,6 ]
Poston, Kathleen L. [1 ,2 ,3 ]
Henderson, Victor W. [1 ,7 ]
Wagner, Anthony D. [2 ,8 ]
Wyss-Coray, Tony [1 ,2 ,3 ]
Mormino, Elizabeth C. [1 ,2 ,9 ]
机构：
[1] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Palo Alto, CA USA
[2] Stanford Univ, Sch Med, Wu Tsai Neurosci Inst, Stanford, CA USA
[3] Stanford Univ, Phil & Penny Knight Initiat Brain Resilience, Stanford, CA USA
[4] Stanford Univ, Dept Genet, Stanford, CA USA
[5] Stanford Univ, Sch Med, Ctr Biomed Informat Res, Stanford, CA USA
[6] Chan Zuckerberg Biohub, San Francisco, CA USA
[7] Stanford Univ, Sch Med, Dept Epidemiol & Populat Hlth, Stanford, CA USA
[8] Stanford Univ, Dept Psychol, Stanford, CA USA
[9] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, 453 Quarry Rd, Palo Alto, CA 94304 USA
来源：
ALZHEIMERS & DEMENTIA | 2024年 / 20卷 / 03期
关键词：
aging; Alzheimer's disease; autophagy; cerebral spinal fluid; clinically unimpaired; protein co-expression network; ubiquitination; AMYLOID-BETA; A-BETA; TAU; AUTOPHAGY; BRAIN; INDIVIDUALS; ASSOCIATION; BIOMARKERS; MECHANISM; PROTEINS;
D O I：
10.1002/alz.13576
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
INTRODUCTION: In this study, we leverage proteomic techniques to identify communities of proteins underlying Alzheimer's disease (AD) risk among clinically unimpaired (CU) older adults.METHODS: We constructed a protein co-expression network using 3869 cerebrospinal fluid (CSF) proteins quantified by SomaLogic, Inc., in a cohort of participants along the AD clinical spectrum. We then replicated this network in an independent cohort of CU older adults and related these modules to clinically-relevant outcomes.RESULTS: We discovered modules enriched for phosphorylation and ubiquitination that were associated with abnormal amyloid status, as well as p-tau181 (M4: beta = 2.44, p < 0.001, M7: beta = 2.57, p < 0.001) and executive function performance (M4: beta = -2.00, p = 0.005, M7: beta = -2.39, p < 0.001).DISCUSSION: In leveraging CSF proteomic data from individuals spanning the clinical spectrum of AD, we highlight the importance of post-translational modifications for early cognitive and pathological changes.
引用
收藏
页码：1851 / 1867
页数：17
相关论文
共 50 条
  • [21] Irreversible dimerization/tetramerization and post-translational modifications inhibit proteolytic degradation of Aβpeptides of Alzheimer's disease
    Kuo, YM
    Webster, S
    Emmerling, MR
    De Lima, N
    Roher, AE
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1998, 1406 (03): : 291 - 298
  • [22] Telmisartan Alleviates Alzheimer's Disease-Related Neuropathologies and Cognitive Impairments
    Fu, Xin-Xin
    Wei, Bin
    Cao, Hai-Ming
    Duan, Rui
    Deng, Yang
    Lian, Hui-Wen
    Zhang, Ying-Dong
    Jiang, Teng
    JOURNAL OF ALZHEIMERS DISEASE, 2023, 94 (03) : 919 - 933
  • [23] Clinical relevance of biomarkers, new therapeutic approaches, and role of post-translational modifications in the pathogenesis of Alzheimer's disease
    Mumtaz, Ibtisam
    Ayaz, Mir Owais
    Khan, Mohamad Sultan
    Manzoor, Umar
    Ganayee, Mohd Azhardin
    Bhat, Aadil Qadir
    Dar, Ghulam Hassan
    Alghamdi, Badrah S.
    Hashem, Anwar M.
    Dar, Mohd Jamal
    Ashraf, Gulam Md.
    Maqbool, Tariq
    FRONTIERS IN AGING NEUROSCIENCE, 2022, 14
  • [24] Histone post-translational modifications in frontal cortex from human donors with Alzheimer’s disease
    Kyle W. Anderson
    Illarion V. Turko
    Clinical Proteomics, 2015, 12
  • [25] Targeting α-synuclein post-translational modifications in Parkinson's disease
    Canever, Jaquelini B.
    Soares, Ericks Sousa
    de Avelar, Nubia C. P.
    Cimarosti, Helena I.
    BEHAVIOURAL BRAIN RESEARCH, 2023, 439
  • [26] Brain microRNAs dysregulation: Implication for missplicing and abnormal post-translational modifications of tau protein in Alzheimer's disease and related tauopathies
    Bazrgar, Maryam
    Khodabakhsh, Pariya
    Mohagheghi, Fatemeh
    Prudencio, Mercedes
    Ahmadiani, Abolhassan
    PHARMACOLOGICAL RESEARCH, 2020, 155
  • [27] Post-translational modifications and age-related hearing loss
    Bazard, Parveen
    Pineros, Jennifer
    Acosta, Alejandro A.
    Thivierge, Mark
    Paganella, Lauren R.
    Zucker, Samuel
    Mannering, Freyda L.
    Modukuri, Shrikar
    Zhu, Xiaoxia
    Frisina, Robert D.
    Ding, Bo
    HEARING RESEARCH, 2022, 426
  • [28] Specific post-translational modifications of soluble tau protein distinguishes Alzheimer's disease and primary tauopathies
    Kyalu Ngoie Zola, Nathalie
    Balty, Clemence
    Pyr dit Ruys, Sebastien
    Vanparys, Axelle A. T.
    Huyghe, Nicolas D. G.
    Herinckx, Gaetan
    Johanns, Manuel
    Boyer, Emilien
    Kienlen-Campard, Pascal
    Rider, Mark H.
    Vertommen, Didier
    Hanseeuw, Bernard J.
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [29] Renal insufficiency and chronic kidney disease - Promotor or consequence of pathological post-translational modifications
    Laget, Jonas
    Duranton, Flore
    Argiles, Angel
    Gayrard, Nathalie
    MOLECULAR ASPECTS OF MEDICINE, 2022, 86
  • [30] Branched-Chain Amino Acids Are Linked with Alzheimer's Disease-Related Pathology and Cognitive Deficits
    Siddik, Md Abu Bakkar
    Mullins, Caitlyn A.
    Kramer, Alyssa
    Shah, Harsh
    Gannaban, Ritchel B.
    Zabet-Moghaddam, Masoud
    Huebinger, Ryan M.
    Hegde, Vijay K.
    MohanKumar, Sheba M. J.
    MohanKumar, Puliyur S.
    Shin, Andrew C.
    CELLS, 2022, 11 (21)
12345